Related Experiment Video
Updated: Apr 30, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Prevention of blindness due to retinopathy of prematurity: a national movement
1Department of Ophthalmology, Vitreo-Retina and Ocular Trauma Unit, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All Indian Institute of Medical Sciences, New Delhi, 110029, India, rajvardhanazad@hotmail.com.
Insights
Retinopathy of Prematurity (ROP) is a leading cause of childhood blindness. Awareness workshops and updated guidelines in India have improved prevention and treatment, including new Anti-VEGF drugs.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Background:
- Retinopathy of Prematurity (ROP) is a significant cause of preventable childhood blindness.
- Increasing NICU admissions in India correlate with a rise in ROP cases due to varied neonatal practices.
Purpose of the Study:
- To detail the initiatives undertaken in India to combat Retinopathy of Prematurity.
- To highlight advancements in ROP prevention, screening, and treatment strategies.
Main Methods:
- Collaborative workshops conducted by WHO, Ministry of Health & Family Welfare, and R.P. Centre, AIIMS.
- Development of India-specific ROP screening and neonatal care guidelines.
- Shift in treatment modalities from cryotherapy/laser to Anti-VEGF agents.
Main Results:
- Increased awareness among neonatologists and ophthalmologists through paired training sessions.
- Establishment of distinct ROP guidelines tailored to Indian practices.
- Promising results with Anti-VEGF therapies, though long-term safety data is pending.
- Inclusion of ROP in the Government of India's blindness control program.
Conclusions:
- Collaborative efforts and targeted workshops have significantly advanced ROP prevention and management in India.
- Integration of governmental and non-governmental efforts is crucial for further reducing ROP incidence.
- While new treatments like Anti-VEGF show promise, ongoing research into long-term outcomes is necessary.
Abstract:
Retinopathy of Prematurity (ROP) has been a blinding disorder and a preventable cause of childhood blindness. With growing interest in pediatric ophthalmology and vitreo-retinal subspecialty, ROP has become increasingly recognized in India. Recently, with rise in number of children admitted to NICU's across India, there has been an increase in number of preterm babies with ROP due to variable neonatal practices. An effort to prevent the disease was taken up by WHO and Ministry of Health & Family Welfare by conducting workshops across India piloted by R.P. Centre, AIIMS. These workshops have gone a long way in spreading awareness amongst both neonatologists and ophthalmologists in paired sessions. Both neonatologists and ophthalmologists complemented each other, discussed ROP prevention and issued ROP screening and good neonatal care guidelines which were different from the American guidelines. Treatment strategies have also undergone a huge change from cryotherapy and laser to anti-vascular endothelial growth factor (Anti-VEGF) drugs which have shown promising results, although caution is to be taken due to lack of data on long-term safety. Overall impact of these workshops led to inclusion of ROP in priority list of blindness control programme of Government of India. Still, ROP prevention needs integration of both governmental and non-governmental agencies, each sharing the load in a complementing way aiding in downward trends of ROP cases.
Related Concept Videos
Diabetic Retinopathy
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Photoreceptors and Visual Pathways
The Retina

